Systemic α-particles are likely to yield more important advances in radiotherapy than are protons

Barry J. Allen, Alexei V. Chvetsov, Colin G. Orton

Research output: Contribution to journalArticlepeer-review

Abstract

New treatment modalities aimed at increasing tumor control and decreasing complications include proton and heavy ion external beam radiotherapies and systemic targeted alphaparticle therapy (TAT). Although proton therapy (PT) has received the most press recently, some would argue that systemic α-particles are likely to yield more important advances than are protons. This is the claim debated in this month’s Point/Counterpoint.
Original languageEnglish
Pages (from-to)3785-3787
Number of pages3
JournalMedical Physics
Volume42
Issue number7
DOIs
Publication statusPublished - 2015

Keywords

  • Boron, neutron capture therapy
  • alpha, radioimmunotherapy
  • gamma rays
  • radiotherapy

Fingerprint

Dive into the research topics of 'Systemic α-particles are likely to yield more important advances in radiotherapy than are protons'. Together they form a unique fingerprint.

Cite this